Home > Insider Trading > Filing (0001415889-25-012166)

Filing Details

Accession Number:: 0001415889-25-012166
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-06 18:52:45
Reporting Period:: 2025-05-02

Filing Date:: 2025-05-06
Accepted Time:: 2025-05-06 18:52:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1847367	Alumis Inc.	ALMS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253170	Srinivas Akkaraju	C/O Alumis Inc. 280 East Grand Avenue South San Francisco CA 94080		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-02	159,920	$4.55	3,426,418	No	4	P	Indirect	By Samsara BioCapital, L.P.
Common Stock	Acquisiton	2025-05-05	138,368	$4.58	3,564,786	No	4	P	Indirect	By Samsara BioCapital, L.P.
Common Stock	Acquisiton	2025-05-05	22,002	$5.27	3,586,788	No	4	P	Indirect	By Samsara BioCapital, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Samsara BioCapital, L.P.
No	4	P	Indirect	By Samsara BioCapital, L.P.
No	4	P	Indirect	By Samsara BioCapital, L.P.

Footnotes

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.97 to $4.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $4.19 to $5.1899 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $5.19 to $5.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.